Achieve Life Sciences earnings were -$111.7M for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. The latest QUIT earnings report on Sep 30, 2026 announced Q3 2026 earnings of -$12.1M, down 83.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, QUIT reported annual earnings of -$54.6M, with 37.2% growth.
Achieve Life Sciences Earnings Reports & History FAQ
What were Achieve Life Sciences's earnings last quarter?
On QUIT's earnings call on Nov 12, 2026, Achieve Life Sciences (NASDAQ: QUIT) reported Q3 2026 earnings per share (EPS) of -$0.11, up 60.71% year over year. Total QUIT earnings for the quarter were -$12.11 million. In the same quarter last year, Achieve Life Sciences's earnings per share (EPS) was -$0.28.
Is Achieve Life Sciences profitable or losing money?
As of the last Achieve Life Sciences earnings report, Achieve Life Sciences is currently losing money. Achieve Life Sciences's net profit (also called net income) for the twelve months ending Sep 30, 2026 was -$111.71 million, a 113.41% increase year over year.
What was QUIT's earnings growth in the past year?
As of Achieve Life Sciences's earnings date in Nov 12, 2026, Achieve Life Sciences's earnings has grown year over year. QUIT earnings in the past year totalled -$111.71 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.